Industry Thought Leaders

Something about what and how we write about, educate, awareness, guidance...
Also a way to contact us to write for their content

Summary of Isolation and Characterization of Impurities in Commercially Marketed Δ8-THC Products

The U.S. cannabis and hemp industry currently lacks comprehensive product characterization, primarily due to limited state testing regulations in this area and a lack of widespread implementation of current Good Manufacturing Practices (cGMP). While most states focus on testing a few active molecules, namely Δ9-THC, Δ9-THCA, CBD, and CBD-A, full identification of product components is generally not required.

Click here to read the full post

Summary of Isolation and Characterization of Impurities in Commercially Marketed Δ8-THC Products

The U.S. cannabis and hemp industry currently lacks comprehensive product characterization, primarily due to limited state testing regulations in this area and a lack of widespread implementation of current Good Manufacturing Practices (cGMP). While most states focus on testing a few active molecules, namely Δ9-THC, Δ9-THCA, CBD, and CBD-A, full identification of product components is generally not required.

Click here to read the full post